Peripheral artery disease affects over 8.5 million Americans, yet most don’t recognise the early warning signs. In this complete guide, we cover the latest diagnostic criteria, evidence-based treatment options for 2026, the critical link between PAD and foot health, and how the right footwear can help prevent complications.
What Is Peripheral Artery Disease? A 2026 Definition
Peripheral artery disease (PAD) is a progressive circulatory condition in which the arteries supplying blood to the limbs — most often the legs — become narrowed or blocked by atherosclerotic plaque. This limits oxygen-rich blood flow to muscles and tissues, especially during activity. In 2026, the global prevalence of PAD is estimated to exceed 240 million cases, with the sharpest rises occurring in low- and middle-income countries.
PAD is more than a leg problem. It is a marker of widespread cardiovascular disease. People with PAD face a 3- to 6-fold increased risk of heart attack and stroke compared to the general population. The condition ranges from asymptomatic (silent PAD) to critical limb-threatening ischaemia (CLTI), the most severe stage, which carries a 25% amputation risk within one year without intervention.
More than half of people with PAD report no classic symptoms. Many dismiss early signs — subtle leg fatigue, mild cramping, or slightly cooler feet — as normal aging. By the time claudication (painful cramping with walking) becomes noticeable, arterial blockages are often already significant. This is why screening awareness and early detection are the cornerstones of modern PAD care in 2026.
6 Warning Signs You Should Never Ignore
Recognising the symptoms of peripheral artery disease early can change the trajectory of the condition. While PAD can present differently in each person, these six signs are the most clinically reliable indicators:
- Intermittent claudication: Cramping, aching, or fatigue in the calves, thighs, or buttocks that occurs with walking a certain distance and resolves after a few minutes of rest. This is the hallmark symptom of PAD.
- Non-healing wounds or sores: Cuts, blisters, or ulcers on the feet or lower legs that take weeks or months to heal indicate poor blood supply to the tissue.
- Coldness in the lower leg or foot: A noticeably cooler temperature in one leg or foot compared to the other is a classic vascular sign.
- Changes in skin colour or texture: Pale, shiny, or bluish-tinged skin on the legs and feet, often accompanied by hair loss on the shins or thickened toenails.
- Weak or absent pulses in the feet or ankles: This finding, detected by a clinician, is a strong indicator of reduced arterial flow.
- Erectile dysfunction in men: Vascular erectile dysfunction can be an early warning sign of systemic atherosclerosis, including PAD.
If you experience a sudden onset of severe leg pain, coldness, numbness, pallor, or paralysis in a limb — especially if you have known cardiovascular disease or risk factors — this may indicate acute limb ischaemia, a medical emergency requiring immediate hospitalisation. Delays of even a few hours can lead to permanent tissue loss.
“PAD is the cardiovascular disease that most commonly flies under the radar. A simple ankle-brachial index test takes 10 minutes and can save a limb — or a life.”
— Dr. Elena Marchetti, Vascular Medicine, Cleveland Clinic (2025)Root Causes & Risk Factors: Why Plaque Builds Up
Peripheral artery disease is caused by atherosclerosis — the same process that leads to coronary artery disease and carotid artery disease. Over years, cholesterol-rich plaque accumulates inside artery walls, narrowing the lumen and reducing blood flow. While the mechanism is uniform, certain factors accelerate plaque formation dramatically.
The Primary Drivers of PAD
- Tobacco use: Smoking is the single strongest modifiable risk factor for PAD. People who smoke are 4 times more likely to develop PAD than non-smokers, and the disease progresses more aggressively in smokers.
- Diabetes mellitus: Diabetes increases PAD risk by 2- to 4-fold. High blood glucose damages the endothelium (artery lining) and promotes plaque formation. Diabetic neuropathy also masks pain, leading to delayed diagnosis.
- Hypertension: Chronic high blood pressure stresses artery walls, making them more vulnerable to plaque deposition.
- Dyslipidaemia: Elevated LDL cholesterol and triglycerides, combined with low HDL cholesterol, accelerate atherosclerosis.
- Chronic kidney disease (CKD): CKD is an independent risk factor for PAD, with severity correlating to CKD stage.
- Age & genetics: PAD prevalence rises sharply after age 60. Family history of early cardiovascular disease also increases risk.
Breakdown by Population Subgroup — who is most at risk in 2026
Data from the 2025 National Health and Nutrition Examination Survey (NHANES) shows that PAD prevalence among U.S. adults over 40 is 7.2%. That rate climbs to 15% in those over 70. Among people with diabetes, it is 25%. Black and Hispanic populations experience disproportionately higher PAD rates (9.8% and 8.4% respectively) and are more likely to present with advanced-stage disease, partly due to differences in screening access and metabolic risk profiles.
How PAD Is Diagnosed: From ABI to Imaging
Diagnosing peripheral artery disease in 2026 is faster and more accurate than ever, yet screening remains underused. The cornerstone of diagnosis is the ankle-brachial index (ABI), a simple, non-invasive test that compares blood pressure in the ankle to blood pressure in the arm.
Normal: 1.00 – 1.40
Borderline: 0.91 – 0.99
Abnormal (PAD): ≤ 0.90
Severe PAD: < 0.50 or > 1.40 (non-compressible vessels, often seen in advanced diabetes)
If ABI is abnormal or clinical suspicion remains high despite a normal ABI (for example in patients with heavily calcified arteries), additional imaging modalities are used:
- Doppler ultrasound with segmental pressures: Provides anatomical mapping of blockages and flow velocities.
- Computed tomography angiography (CTA): Produces high-resolution 3D images of the entire lower-limb arterial tree.
- Magnetic resonance angiography (MRA): A non-ionising alternative, particularly useful for patients with renal impairment.
- Invasive angiography: Utilised primarily when endovascular intervention is planned.
“The ABI is as important for detecting PAD as the mammogram is for breast cancer. It takes 10 minutes, costs virtually nothing, and has a 95% sensitivity for detecting haemodynamically significant stenosis.”
— Dr. James O’Sullivan, Interventional Cardiologist, Mayo Clinic (2026)Treatment Pathways for 2026: Medications, Procedures & Lifestyle
Treatment for peripheral artery disease is multi-layered. The goal is three-fold: relieve symptoms, slow disease progression, and reduce the risk of major adverse cardiovascular events (heart attack, stroke, death). In 2026, the armamentarium includes pharmacotherapy, supervised exercise, endovascular and surgical options, and aggressive risk factor management.
First-Line Pharmacotherapy
- Anti-platelet therapy: Low-dose aspirin (75–100 mg daily) or clopidogrel is standard for symptomatic PAD. Dual anti-platelet therapy is used after revascularisation.
- Statin therapy: High-intensity statin (e.g., atorvastatin 40–80 mg) regardless of baseline cholesterol — statins reduce cardiovascular events and improve walking distance.
- Cilostazol: A phosphodiesterase-3 inhibitor that improves walking distance by vasodilation and anti-platelet effects. It is the only symptom-specific medication approved for claudication.
- Rivaroxaban + aspirin: The COMPASS trial (2017) and subsequent guidelines now recommend low-dose rivaroxaban (2.5 mg twice daily) plus aspirin for high-risk PAD patients — this regimen reduces major adverse limb and cardiovascular events.
- Antihypertensives & glucose control: ACE inhibitors, ARBs, and SGLT2 inhibitors offer both vascular and metabolic benefits.
Endovascular & Surgical Revascularisation
When claudication severely limits quality of life or when critical limb ischaemia develops, revascularisation is indicated. Options include balloon angioplasty with or without stenting, atherectomy, and surgical bypass grafting using autologous vein or prosthetic graft. Drug-coated balloons and drug-eluting stents have improved patency rates in the femoropopliteal segment, though concerns around late mortality with paclitaxel devices (raised in a 2018 meta-analysis) have led to more selective use and rigorous patient counselling as of 2026.
Endovascular — Focal, short-segment blockages in larger vessels; patients with high surgical risk; claudication that limits daily activities.
Surgical bypass — Long-segment or multi-level occlusions; failed prior endovascular treatment; critical limb ischaemia with extensive tissue loss.
Supervised Exercise Therapy (SET)
SET is a cornerstone of claudication management and is now covered by Medicare for PAD. A typical program includes 30–60 minutes of intermittent walking (walk until moderate claudication, rest, repeat) three times per week for 12 weeks. Meta-analyses show SET improves pain-free walking distance by 150–200% — comparable to or better than cilostazol, with no side effects.
If you have claudication, walk “through” the pain to the point of moderate discomfort (not severe pain), then rest until the pain subsides. This stimulates collateral circulation — the growth of small “detour” blood vessels that bypass blockages. Over time, walking distance often improves dramatically.
Footwear & Foot Care: The Overlooked Lifeline in PAD Management
For people with peripheral artery disease, foot health is not a minor detail — it is a central pillar of disease management. Poor circulation means that even a small blister, callus, or ingrown toenail can rapidly progress to a non-healing ulcer, infection, and potentially amputation. The right footwear, combined with daily foot inspections, is the single most effective prevention strategy.
What Makes a Shoe Safe for PAD?
Not all shoes are equal when it comes to protecting PAD-affected feet. Here are the five critical footwear factors:
Every person with PAD should perform a brief foot check each evening. Use a mirror to inspect the soles, look between toes for cracks or blisters, and note any colour changes, swelling, or warmth. If you cannot see your feet well, ask a partner or caregiver to check. The moment you spot a new lesion, contact your podiatrist or vascular specialist — do not “wait and see.” Early intervention can prevent a minor wound from becoming a limb-threatening issue.
Myths vs. Facts: What Every Patient Needs to Know
Misconceptions about peripheral artery disease are widespread — even among some healthcare providers. Here we separate fact from fiction using the latest evidence.
Rest worsens PAD. Regular walking — even when it causes mild claudication — stimulates collateral blood vessel growth (angiogenesis) and can dramatically improve walking distance. The evidence for supervised exercise therapy is Grade A. Of course, rest is needed when a wound or ulcer is present, but for claudication without tissue loss, movement is medicine.
A normal resting ABI (1.00–1.40) does not rule out PAD, especially in patients with diabetes or chronic kidney disease, whose arteries may be calcified and non-compressible, producing a falsely elevated ABI. In these cases, a toe-brachial index (TBI) or doppler waveform analysis is needed. Also, a resting ABI can be normal if the blockage is only haemodynamically significant during exercise — a post-exercise ABI is the appropriate test.
It is true that PAD prevalence rises steeply after age 60 and that smoking is the strongest modifiable risk factor — but PAD can affect younger adults, particularly those with diabetes, chronic kidney disease, or a strong family history of premature cardiovascular disease. Rates of PAD in people under 50 with type 2 diabetes have increased 40% in the last decade. No one is too young for PAD screening if risk factors are present.
This is false and dangerous. The American College of Cardiology and American Heart Association guidelines recommend high-intensity statin therapy for all patients with symptomatic PAD, regardless of baseline LDL levels. Statins reduce major cardiovascular events and mortality in PAD by 20–30%, and they also improve claudication symptoms independently of their cholesterol-lowering effect through plaque stabilisation and endothelial function improvement.
Frequently Asked Questions About Peripheral Artery Disease
Can peripheral artery disease be reversed?
PAD cannot be fully “reversed” in the sense that existing plaque is eliminated. However, with aggressive risk factor control (smoking cessation, statin therapy, blood pressure and blood sugar management) and regular exercise, the disease can be stabilised, symptoms can improve, and progression can be halted. In some cases, collateral circulation can develop to the point where functional symptoms disappear. Critical limb ischaemia, however, requires revascularisation to restore adequate flow.
How fast does PAD progress?
PAD progression is highly variable. In people who continue to smoke or have poorly controlled diabetes, the disease can advance rapidly — symptomatic claudication may develop into critical limb ischaemia within 2–5 years. In non-smokers with well-controlled risk factors, PAD may remain stable for decades. Annual ABI testing and symptom tracking are the best ways to monitor progression. Any sudden worsening of symptoms — such as a sharp drop in walking distance or the appearance of rest pain — should be evaluated promptly.
What is the difference between PAD and venous insufficiency?
Peripheral artery disease involves blocked or narrowed arteries (vessels carrying oxygen-rich blood from the heart to the limbs). Symptoms include claudication, cool feet, weak pulses, and non-healing wounds on the toes or pressure points. Chronic venous insufficiency involves damaged veins (vessels returning blood to the heart) and leads to pooling of blood in the lower legs. Symptoms include swelling (oedema), aching that improves with walking, varicose veins, hyperpigmentation (brownish skin around the ankles), and ulcers typically located above the medial malleolus (inner ankle). It is possible to have both conditions simultaneously, which requires careful diagnostic differentiation because treatments differ fundamentally.
Does walking barefoot help or hurt PAD?
For people with PAD — especially those with co-existing neuropathy or diabetes — walking barefoot is strongly discouraged. Without protective footwear, even a tiny cut, puncture, or blister can go unnoticed and become infected. Barefoot walking also does not stimulate collateral circulation more than walking in well-cushioned, supportive shoes. The risks far outweigh any theoretical benefit. Always wear clean, well-fitting shoes and moisture-wicking socks, even indoors.
When is surgery necessary for PAD?
Surgery (or endovascular intervention) is indicated when: (1) claudication severely limits daily activities despite optimal medical therapy and exercise for ≥ 3 months; (2) critical limb ischaemia is present — rest pain, non-healing ulcer, or gangrene; (3) acute limb ischaemia occurs (a vascular emergency). For most patients with claudication alone, a trial of cilostazol and supervised exercise for 12–16 weeks is recommended before pursuing revascularisation. Surgery is not the first step — it is reserved for when symptoms are disabling or tissue is at risk.
Can I fly with peripheral artery disease?
Yes, but with precautions. Long flights (≥ 4 hours) involve prolonged sitting, which reduces blood flow to the legs and increases the risk of deep vein thrombosis (DVT) — a separate condition but one that compounds the risk in PAD. Preventive measures include: wearing compression stockings (15–20 mmHg or as prescribed), standing and walking the aisle every 60–90 minutes, performing seated ankle pumps (point and flex feet repeatedly), staying hydrated, and avoiding alcohol or sedatives during the flight. If you have critical limb ischaemia or a recent revascularisation (within 2 weeks), consult your vascular surgeon before booking air travel.
You may also like
-
Skechers Women’s Glide-Step Altus Hands Free Slip-Ins
$69.97 -
QIY Sneakers for Women Casual Lightweight Tennis Shoes Comfortable Lace up Women’s Wide Toe Fashion Sneakers
$19.99 -
somiliss Wide Toe Box Shoes Women Comfortable Arch Support Fashion Sneakers Breathable Trendy Casual Women’s Walking Shoes Non Slip Office Classic Shoes
$62.90 -
NORTIV 8 Women’s Water Shoes Barefoot Quick Dry Aqua Swim Shoes for Beach Sports Fishing Hiking Boating Surfing Shoes TREKLADY
$19.99